Background illustration for clinical trials search

Paid Clinical Trials Knoxville

Discover 213 paid clinical trials in Knoxville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Knoxville TN, Birmingham AL, Washington D.C. DC,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07091630

Phase 3, Recruiting
New

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

for
Lumbosacral Radiculopathy
Location: Knoxville TN, Winston-Salem NC, Monroe NC,
Sponsor: Vertanical GmbH

Sex: All

Age: 18+

Code: NCT06956014

Phase 3, Recruiting

AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

for
ALS
Location: Knoxville TN, Jacksonville FL, Washington D.C. DC,
Sponsor: Amylyx Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06665165

Phase 1, Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

for
Adjustment Disorder
Location: Knoxville TN, Atlanta GA, Birmingham AL, Chapel Hill NC,
Sponsor: Reunion Neuroscience Inc

Sex: All

Age: 18 - 70+

Code: NCT07002034

Phase 2, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Knoxville TN, Anderson SC, Atlanta GA, Louisville KY,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Knoxville TN, Lexington KY, Atlanta GA, Nashville TN,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Knoxville TN, Asheville NC, Aurora CO, Locust Grove GA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

for
Breast Cancer
Location: Knoxville TN, Rochester MI, Wynnewood PA, Naples FL,
Sponsor: Sanarus Technologies, Inc.

Sex: Female

Age: 50+

Code: NCT01992250

Recruiting
New

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

for
Androgenetic Alopecia
Location: Knoxville TN, Smyrna TN, Atlanta GA, Birmingham AL,
Sponsor: Pelage Pharmaceuticals, Inc.

Sex: Male

Age: 18 - 55

Code: NCT07819435

Phase 2, Phase 3, Recruiting

Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

for
Psoriasis
Location: Knoxville TN, San Antonio TX, West Jordan UT,
Sponsor: Illumicure Inc

Sex: All

Age: 18+

Code: NCT03180866

Recruiting

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

for
Actinic Keratosis
Location: Knoxville TN, Greenville SC, Anderson SC, Nashville TN,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144852

Phase 3, Recruiting

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

for
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III,
Location: Knoxville TN
Sponsor: Thompson Cancer Survival Center

Sex: Female

Age: 18+

Code: NCT06006806

Recruiting

Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy

for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Knoxville TN
Sponsor: Thompson Cancer Survival Center

Sex: All

Age: 18+

Code: NCT06183268

Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Knoxville TN, Atlanta GA, Franklin TN, Charlotte NC,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement

for
Prostate Cancer, Prostate Adenocarcinoma, Prostate Carcinoma
Location: Knoxville TN
Sponsor: Thompson Cancer Survival Center

Sex: Male

Age: 18+

Code: NCT06200259

Recruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Knoxville TN, Chapel Hill NC, Chicago IL, Danville PA,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05530343

Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Knoxville TN, Winder GA, Dublin GA, Wilmington NC,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

for
Bronchiectasis
Location: Knoxville TN, Anderson SC, Spartanburg SC, Union SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07201051

Phase 2, Recruiting

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for
Pulmonary Disease, Chronic Obstructive
Location: Knoxville TN, Greenville SC, Dunwoody GA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07177339

Phase 3, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Knoxville TN, Adairsville GA, Spartanburg SC, Shelby NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting